nDatalyze announces a new President and Chief Psychiatric Officer – October 25, 2023



nDatalyze Corp. (“NDAT” or the “Corporation”) (CSE:NDAT) (OTC:NDATF) announces a new President and Chief Psychiatric Officer.


Calgary, Alberta – October 25, 2023

For Immediate Release – nDatalyze Corp. (“NDAT” or the “Corporation”) (CSE:NDAT) (OTC:NDATF) is very pleased to announce the appointment of Dr. Keith Courtney to the position of President and Chief Psychiatric Officer. The appointment is effective immediately.

Dr. Courtney is a board-certified psychiatrist who has been practicing since 1995. Dr. Courtney graduated from the Chicago College of Osteopathic Medicine in 1990. He completed his residency in general psychiatry at Louisiana State University in New Orleans and a fellowship in cross-cultural psychiatry at the University of Minnesota. He is board-certified by the American Board of Psychiatry and Neurology and is a fellow of the American Society of Addictions Medicine. He has been on the faculties of Dartmouth University, the University of Vermont, Louisiana State University, and the University of Nevada. He is currently on the faculty of the University of Calgary where he supervises residents and medical students. Dr. Courtney’s areas of interest include psychiatric assessment, psychopharmacology, psychotherapy (including psychodynamic psychotherapy, cognitive-behavioural therapy, mindfulness-based therapies, and others), sports and performance arts mental health issues, psychedelic therapies, and complementary and alternative psychiatric interventions. He has a certification in Ketamine-Assisted Psychotherapy from the Integrative Psychiatry Institute and is Medical Director of BLOOM Psychedelic Therapy and Research Institute. Effective immediately, the Company’s current President, Jim Durward, will move to the position of Chief Technical Officer (“CTO”).

James Durward, CTO, states: “I am so pleased to have Dr. Courtney as our new President. He has been involved with YMI since the beginning and was instrumental in the mental condition scoring algorithm that guides YMI’s supervised-machine-learning predictions. I expect his experience will be an accelerating force for the acceptance of YMI as an advanced predictive mental condition and prescription system and I very much look forward to working with him during our Clinical Study.”



YMI uses evidence-based, objective data from whole life experiences to predict individual mental states over time and applies this knowledge towards a fuller understanding of how mental health develops and to improve mental wellbeing. YMI combines machine-learning with a proprietary Reference Database that contains >1200 person’s genetic expressions, childhood environment, habits, phobias, lived experiences and lifestyle to generate a personalized graphic report predicting an individual’s predisposition toward a variety of common mental conditions, both current and forward in time.



nDatalyze Corp.
James Durward, CTO
Telephone: (403) 689-3901
Email: [email protected]

Website: www.ndatalyze.com

YMI Website: https://ymihealth.ca


Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Corporation believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.